Global Biotech Ingredients Market Ascends at a Noteworthy CAGR of 9%

Chemical substances used in biotech ingredients are analogous to those in nature. Similar to natural ingredients, these ingredients are created using a variety of complex procedures and frameworks. These substances are produced using various technologies, including gene transfer, hybridoma technology, recombinant DNA technology, and genetic engineering. Genetically modified yeast and bacteria are used to produce biotech ingredients.

Market Dynamics

Changing Consumers' Preferences for Bio-Based Ingredients over Synthetic Drives the Global Market

Consumers are more informed about the ingredients and manufacturing processes of scented goods, herbs, and personal care products. Concern over these products' harmful effects on oneself and the environment has significantly increased. As a result, consumers are switching from synthetic to herbal and organic products in their consumption patterns. Additionally, as chronic diseases like cancer have become more prevalent, consumer preferences have changed to favor natural and organic products.

Favorable Governmental Initiatives and Improvements in Bioengineering Technology Creates Tremendous Opportunities

The growing acceptance of biopharmaceuticals is expected to drive growth in the market for biotech ingredients. Governments must put policies in place to assist producers and reduce production costs. Additionally, the approval procedure for synthetic goods is much more straightforward than for biotechnologically generated goods, which frequently require time-consuming additional approval procedures. Therefore, streamlined approval processes and encouraging laws can generate a lot of chances for market expansion.

Regional Analysis

Europe is the most significant shareholder in the global biotech ingredients market and is expected to grow at a CAGR of 5.1% during the forecast period. Germany, followed by France, holds the largest market share in the region. The smallest market share belongs to Italy. Europe, a significant consumer of the product, uses a sizable portion of domestically produced biotech ingredients. Biotech ingredients are highly sought-after in the region because of their advantage in reducing unfavorable side effects and the sizeable consumer base that favors natural and organic products.

Asia-Pacific is expected to grow at a CAGR of 5.3%, generating USD 27,636.79 million during the forecast period. China, followed by India, holds the largest market share in the region. The country with the smallest market share in South Korea. Since Asia-Pacific is a significant pharmaceutical producer, there is a high demand for biotech ingredients. Biotech ingredients are increasingly in demand in medicine, food and beverage, personal care, and cosmetics due to their organic nature and environmental friendliness.

North America is expected to grow significantly over the forecast period. This is attributed to a rise in the local activity of biotech ingredient expression systems. The existence of sizable industrial and manufacturing conglomerates is a driving force behind the demand for biotech ingredients. Another significant factor influencing the market for biotech ingredients in North America is the expansion of the Mexican market for microbial expression systems. Additionally, the market expansion is aided by the rising popularity of organic products in the US and Canada.

Key Highlights

• The biotech ingredients market was valued at USD 1.84 billion in 2021. It is expected to reach USD 4 billion by 2030, growing at a CAGR of 9% during the forecast period (2022–2030).
• Based on type, the global biotech ingredients market is bifurcated into active pharmaceuticals ingredients (APIs) and biosimilars. The active pharmaceuticals ingredients (APIs) segment is the highest contributor to the market and is expected to grow at a CAGR of 4.8% during the forecast period.
• Based on the product, the global biotech ingredients market is bifurcated into monoclonal antibodies, vaccines, hormones and growth factors, cytokines, fusion proteins, therapeutic enzymes, and blood factors. The monoclonal antibodies segment owns the highest market share and is expected to grow at a CAGR of 5.2% during the forecast period.
• Based on the expression system, the global biotech ingredients market is bifurcated into mammalian expression systems, microbial expression systems, yeast expression systems, plant expression systems, and insect expression systems. The microbial expression systems segment is the highest contributor to the market and is expected to grow at a CAGR of 5% during the forecast period.
• Europe is the most significant shareholder in the global biotech ingredients market and is expected to grow at a CAGR of 5.1% during the forecast period.

Market Segments

Global Biotech Ingredients Market: Segmentation

By Type

• Active Pharmaceuticals Ingredients (APIs)
• Biosimilars

By Products

• Monoclonal antibodies
• Vaccines
• Hormones and Growth Factors
• Cytokines
• Fusion Proteins
• Therapeutic Enzymes
• Blood Factors

By Expression System

• Mammalian Expression Systems
• Microbial Expression Systems
• Yeast Expression Systems
• Plant Expression Systems
• Insect Expression Systems

By Regions

• North America
• Europe
• Asia-Pacific
• LAMEA